Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amr El Nashar"'
Autor:
Maram Salama, Sonia Ahmed, Sonya Soliman, Nahla El-Sharkawy, Sherine Salem, Amr El-Nashar, Reham Khedr, Leslie Lehmann, Iman Sidhom, Alaa El-Haddad
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMixed-phenotype acute leukemia (MPAL) in children is an uncommon subtype of acute leukemia that cannot be definitively assigned to a specific lineage. There is no consensus on the best approach to therapy. Management is more complex in low
Externí odkaz:
https://doaj.org/article/fa50ee137eae47e8a6f25fa69a9964a0
Publikováno v:
Bulletin of the Faculty of Engineering. Mansoura University. 39:8-22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6825523570e1548ea62b878867d7c6c4
https://doi.org/10.21608/bfemu.2020.103093
https://doi.org/10.21608/bfemu.2020.103093
Autor:
Khaled Shaaban, Nesreen Aly, Dina Yassin, Nayera Hamdy, Alaa Elhaddad, Sarah Hesham, Wafaa M. Rashed, Hala Reda, Abeer Mokhles, Sherine Salem, Sonya Soliman, Mai Mahmoud, Iman Sidhom, Amr El Nashar
Publikováno v:
Clinical Cancer Research. 21:B07-B07
Introduction: Childhood acute lymphoblastic leukemia (ALL) is a highly heterogeneous disease with distinct biological subgroups. Objective: To detect the incidence of the most common fusion gene transcripts in a large cohort of de novo Egyptian pedia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::941adeb925e72daf619e671126896a04
https://doi.org/10.1158/1557-3265.hemmal14-b07
https://doi.org/10.1158/1557-3265.hemmal14-b07
Autor:
Nesreen Ali, Sarah Youssef, Magda M. Assem, Iman Attia, Nayera Hamdy, Khaled Shaaban, Amr El Nashar, Sherine Salem, Dina Yassin, Wafaa M. Rashed, Sonya Soliman, Iman Sidhom, Seham Gohar
Publikováno v:
Journal of Clinical Oncology. 33:e21008-e21008
e21008 Background: Minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) during the early stages of therapy is statistically significant indicator of outcome. Aim: To study...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d8814c9fe1b7c5c0645e73f9ab1bb76
https://doi.org/10.1200/jco.2015.33.15_suppl.e21008
https://doi.org/10.1200/jco.2015.33.15_suppl.e21008
Autor:
Amr El-Nashar, Alaa Elhaddad, Sherine Salem, Hala Hassanein, Hadeel Magdi, Khaled Shaaban, Abir Mokhles, Waffa Rashed, Nayera Hamdy, Sonya Soliman, Dina Yassin, Iman Sidhom
Publikováno v:
Journal of Clinical Oncology. 31:10044-10044
10044 Background: With modern risk directed therapy, >80% of children with acute lymphoblastic leukemia (ALL) in western countries are cured. The 5-year event free survival (EFS) and relapse free survival (RFS) of pediatric ALL patients in Egypt were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99c4949dbdc53c68ded2388c4082b9f6
https://doi.org/10.1200/jco.2013.31.15_suppl.10044
https://doi.org/10.1200/jco.2013.31.15_suppl.10044